| MLOAX | VENAX | MLOAX / VENAX | |
| Total Expense Ratio | 1.25 | 0.09 | 1,389% |
| Annual Report Gross Expense Ratio | 1.65 | 0.09 | 1,833% |
| Fund Existence | 12 years | 21 years | - |
| Gain YTD | 18.797 | 4.938 | 381% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 0 | 100000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 122M | 8.66B | 1% |
| Annual Yield % from dividends | 4.07 | 3.09 | 132% |
| Returns for 1 year | 13.53 | -5.10 | -265% |
| Returns for 3 years | 40.33 | -0.78 | -5,190% |
| Returns for 5 years | 157.88 | 161.98 | 97% |
| Returns for 10 years | 111.03 | 38.02 | 292% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FGSAX | 61.94 | 0.07 | +0.11% |
| Federated Hermes MDT Mid Cap Growth A | |||
| CNPSX | 60.17 | N/A | N/A |
| Consumer Staples UltraSector ProFund Svc | |||
| FMFMX | 18.02 | N/A | N/A |
| Fidelity Advisor Series Equity Gr | |||
| IVITX | 19.74 | -0.03 | -0.15% |
| VY® Invesco Growth and Income S2 | |||
| BRWSX | 28.05 | -0.32 | -1.13% |
| MFS Blended Research Growth Eq R2 | |||